References
- Rowaiye AB, Nwonu EJ, Asala TM, et al. Identifying immunodominant multi-epitopes from the envelope glycoprotein of the lassa mammarenavirus as vaccine candidate for Lassa fever. Clin Exp Vaccine Res 2022;11:249-63. https://doi.org/10.7774/cevr.2022.11.3.249
- Fisher-Hoch SP, McCormick JB. Lassa fever vaccine. Expert Rev Vaccines 2004;3:189-97. https://doi.org/10.1586/14760584.3.2.189
- Balogun OO, Akande OW, Hamer DH. Lassa fever: an evolving emergency in West Africa. Am J Trop Med Hyg 2020;104:466-73. https://doi.org/10.4269/ajtmh.20-0487
- Sulis G, Peebles A, Basta NE. Lassa fever vaccine candidates: a scoping review of vaccine clinical trials. Trop Med Int Health 2023;28:420-31. https://doi.org/10.1111/tmi.13876